IN DEPTH: The NCI Subscription Deal with Celera | GenomeWeb

NEW YORK, July 11 – In the often-contentious world of private versus public genomic initiatives, everybody appears to be happy about the National Cancer Institute’s subscription agreement with Celera Genomics.

The deal, which allows individual NCI principal investigators to use lab budgets to access the data and tools in the Celera Discovery System and mouse and SNP datasets, was six months in the making, according to sources at NCI and Celera. The agreement was announced on Monday. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.